Partin Tables update 2016: Organ confined disease
Objective of the study was to update the Partin Tables for prediction of pathological stage in the contemporary setting and examine trends in patients treated with radical prostatectomy (RP) over the past
three decades.
Research authors: Jeffrey T. Tosoian, Meera Chappidi, Zhaoyong Feng, Elizabeth B. Humphreys, Misop Han, Christian P. Pavlovich, Jonathan I. Epstein, Alan W. Partin, Bruce J. Trock
Details Formula Study characteristics Files & References
Model author
Model ID
Revision date
MeSH terms
  • Partin Tables
  • Prostate Cancer
  • Prostate Specific Antigen
  • Gleason Score
  • Model type
    R-Script model (Calculation)
    No Formula defined yet
    Condition Formula

    Additional information

    From January 2010 to October 2015, 4459 men meeting inclusion criteria underwent RP and pelvic lymphadenectomy for histologically confirmed prostate cancer at the Johns Hopkins Hospital. Preoperative clinical stage, serum prostate specific antigen (PSA) level, and biopsy Gleason score (i.e. prognostic Grade Group) were used in a polychotomous logistic regression model to predict the probability of pathological outcomes categorised as: organ-confined (OC), extraprostatic extension (EPE), seminal vesicle involvement (SV+), or lymph node involvement (LN+).

    Study Population

    Total population size: 4459
    Males: {{ model.numberOfMales }}
    Females: {{ model.numberOfFemales }}

    Continuous characteristics

    Name Mean SD Unit
    Age 59.5 7.0 years
    PSA 5.7 5.1 ng/ml

    Categorical characteristics

    Name Subset / Group Nr. of patients
    Race White 3505
    African american 587
    Hispanic 81
    Asian 64
    Other 221
    PSA Groups (ng/ml) 0-2.5 760
    2.6-4.0 680
    4.1-6.0 1584
    6.1-10.0 1038
    >10.0 397
    Biopsy gleason score ≤6 2112
    3 + 4 = 7 1336
    4 + 3 = 7 564
    8 256
    9-10 191
    Clinical stage (AJCC-TNM 2002) T1c 3514
    T2a 651
    T2b 243
    T2c 51
    Prostatectomy gleason score ≤6 1617
    3 + 4 1687
    4 + 3 664
    8 211
    9-10 271
    Cancer state Organ confined 3278
    Extraprostatic Extension (SV-, LN-) 898
    Seminal Vesicle involvement (LN-) 182
    Lymph node involvement 101
    Partin Tables update 2016: Organ confined disease
    Refer to Intended Use for instructions before use
    Evidencio B.V., Irenesingel 19, 7481 GJ, Haaksbergen, the Netherlands

    Related files

    Supporting Publications

    Calculated risk for organ confined disease is:

    {{ resultSubheader }}

    {{ model.survival.PITTitle }}

    {{ model.survival.YNETitle }}

    Notes are only visible in the result download and will not be saved by Evidencio

    Calculated risk for organ confined disease is: %

    {{ resultSubheader }}
    {{ chart.title }}

    Outcome stratification

    Result interval {{ additionalResult.min }} to {{ additionalResult.max }}

    Conditional information

    Result interpretation

    Knowing the chance of organ confined disease in prostate cancer patients might help the clinician to make a decision regarding best possible treatment. 

    Confidence intervals of the calculated chances can be found in the table below. 

    {{ file.classification }}

    Calculations alone should never dictate patient care, and are no substitute for professional judgement. See our full disclaimer.

    Please enter a comment of rating
    Comments are visible to anyone

    Model feedback

    No feedback yet 1 Comment {{ model.comments.length }} Comments
    Not rated | On {{ comment.created_at }} {{ comment.user.username }} a no longer registered author wrote:

    Please sign in to enable Evidencio print features

    In order to use the Evidencio print features, you need to be logged in.
    If you don't have an Evidencio Community Account you can create your free personal account at:

    Printed results - Examples {{ new Date().toLocaleString() }}

    Evidencio Community Account Benefits

    With an Evidencio Community account you can:

    • Create and publish your own prediction models.
    • Share your prediction models with your colleagues, research group, organization or the world.
    • Review and provide feedback on models that have been shared with you.
    • Validate your models and validate models from other users.
    • Find models based on Title, Keyword, Author, Institute, or MeSH classification.
    • Use and save prediction models and their data.
    • Use patient specific protocols and guidelines based on sequential models and decision trees.
    • Stay up-to-date with new models in your field as they are published.
    • Create your own lists of favorite models and topics.
    A personal Evidencio account is free, with no strings attached! Join us and help create clarity, transparency, and efficiency in the creation, validation, and use of medical prediction models.

    Disclaimer: Calculations alone should never dictate patient care, and are no substitute for professional judgement.